Publications
82
Citations
1,216
Est. group size
—
Recurring co-author estimate
Active years
24
Publishing since 2003
Steven Ing's research focuses on metabolic bone and mineral disorders, particularly hypoparathyroidism and hypophosphatasia, two conditions affecting calcium and bone metabolism. His work includes clinical trials of hormone-replacement therapies, patient-reported outcome measures, disease registries, and diagnostic criteria development, as well as broader studies on osteoporosis and bone density in different patient populations.
Publication output has grown over the last decade, rising from about 4 papers per year in 2017 to a peak of 13 in 2024, with an average of roughly 7 per year over the last five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Burden of disease in US patients with skeletal versus muscular or pain manifestations of hypophosphatasia: An analysis from the Global HPP Registry
Bone · 2026
- Early U.S. Real-World Treatment Patterns and Outcomes in Palopegteriparatide Treatment for Patients With Hypoparathyroidism
Endocrine Practice · 2025
- rhPTH(1-84) for hypoparathyroidism: a randomized study of patient-reported outcomes
European Journal of Endocrinology · 2025
- SUN-765 Retrospective Analysis of Pregnancy and Neonatal Outcomes in Hypoparathyroidism from the PARADIGHM Registry
Journal of the Endocrine Society · 2025
- Improvement in quality of life after asfotase alfa treatment in adults with pediatric-onset hypophosphatasia: data from 5 patient-reported outcome measures
JBMR Plus · 2024
- Fractures by race and ethnicity in a diverse sample of postmenopausal women: a current evaluation among Hispanic and Asian origin groups
Journal of Bone and Mineral Research · 2024
- Response rates for lumbar spine, total hip, and femoral neck bone mineral density in men treated with abaloparatide: results from the ATOM study
JBMR Plus · 2024
- Open-label extension of a randomized trial investigating safety and efficacy of rhPTH(1–84) in hypoparathyroidism
JBMR Plus · 2024
- Correction: Hypophosphatasia diagnosis: current state of the art and proposed diagnostic criteria for children and adults
Osteoporosis International · 2024
- Hypophosphatasia diagnosis: current state of the art and proposed diagnostic criteria for children and adults
Osteoporosis International · 2023
- The challenge of hypophosphatasia diagnosis in adults: results from the HPP International Working Group Literature Surveillance
Osteoporosis International · 2023
- Proposed diagnostic criteria for the diagnosis of hypophosphatasia in children and adolescents: results from the HPP International Working Group
Osteoporosis International · 2023
- Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review
PharmacoEconomics · 2023
- Psychometric Analysis of the Patient-Reported Hypoparathyroidism Symptom Diary Symptom Subscale Using Data from Two Clinical Trials
Patient Related Outcome Measures · 2023
- A Phase I Randomized Trial of Once‐Daily Versus <scp>Twice‐Daily</scp> Recombinant Human Parathyroid Hormone (1‐84) for Hypoparathyroidism
JBMR Plus · 2023
- Journal of the Endocrine Society×11
- JBMR Plus×6
- Osteoporosis International×4
- Journal of Bone and Mineral Research×4
- Endocrine Practice×3
- Kathleen M. Hill Gallant
Medicine · Purdue University West Lafayette
- Kalisha O’Neill
Medicine · Indiana University
- Sijie Chen
Medicine · The Ohio State University
- Erik A. Imel
Medicine · Indiana University
- Sharon M. Moe
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile